Yervoy
Showing 26 - 50 of 376
Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Nivolumab, Ipilimumab, Radiation)
Active, not recruiting
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Nivolumab
- +2 more
-
Boston, Massachusetts
- +2 more
Sep 7, 2022
Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)
Recruiting
- Pancreatic Cancer
- Tadalafil
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 23, 2022
Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev
Recruiting
- Prostate Cancer Metastatic
- +3 more
- Stereotactic body radiotherapy
- +3 more
-
Herlev, Capital Region, DenmarkDepartment of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022
Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)
Recruiting
- Metastatic Cancer
- Keytruda Injectable Product
- +4 more
-
Rochester, MichiganAscension Providence Rochester Hospital
Jun 15, 2022
Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)
Recruiting
- Metastatic Melanoma
- Metastasis to Brain
- Nivolumab
- +3 more
-
Tampa, Florida
- +1 more
Jan 30, 2023
Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)
Recruiting
- Metastatic Soft-tissue Sarcoma
- Cabozantinib
- +2 more
-
Stanford, California
- +3 more
Jan 10, 2023
NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)
Not yet recruiting
- NSCLC Stage IV
- +4 more
- Nivolumab and Ipilimumab
-
Verona, Veneto/Verona, ItalyCentro Ricerche Cliniche
Oct 26, 2022
Pancreatic Cancer Trial in Herlev (drug, biological, radiation)
Recruiting
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev and Gentofte Hospital
Mar 15, 2022
Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Merkel Cell Carcinoma
- Skin Cancer
- Nivolumab
- +2 more
-
Tampa, Florida
- +1 more
Nov 11, 2022
Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,
Completed
- Metastatic Prostatic Adenocarcinoma
- Opdivo Injectable Product
- +3 more
-
Lancaster, California
- +1 more
Jun 15, 2022
Colorectal Tumors Malignant, Liver Metastases Trial in Ramat Gan (Liver radiation therapy, Nivolumab Injection [Opdivo],
Active, not recruiting
- Colorectal Neoplasms Malignant
- Liver Metastases
- Liver radiation therapy
- +3 more
-
Ramat Gan, IsraelSheba Medical Center
May 20, 2022
Urothelial Carcinoma, Bladder Cancer Trial in Rotterdam, Utrecht (Ipilimumab + nivolumab)
Active, not recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Ipilimumab + nivolumab
-
Rotterdam, Netherlands
- +1 more
Apr 14, 2022
Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)
Completed
- Non-small Cell Lung Carcinoma
- Pembrolizumab
- +7 more
- (no location specified)
Oct 13, 2022
Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)
Not yet recruiting
- Renal Cell Carcinoma
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Pancreatic Cancer Trial in Herlev (Nivolumab, Ipilimumab, Tocilizumab)
Terminated
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev & Gentofte University Hospital, Denmark
Mar 15, 2022
Kidney Cancer Trial in Boston (NeoVax, Ipilimumab)
Recruiting
- Kidney Cancer
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 22, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)
Recruiting
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- SD-101
- +3 more
-
New York, New York
- +3 more
Oct 19, 2022